AGIO - Agios Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.86B
Enterprise Value 32.4B
Trailing P/E N/A
Forward P/E 1-7.58
PEG Ratio (5 yr expected) 1-0.18
Price/Sales (ttm)24.71
Price/Book (mrq)4.61
Enterprise Value/Revenue 320.70
Enterprise Value/EBITDA 6-6.69

Trading Information

Stock Price History

Beta (3Y Monthly) 2.24
52-Week Change 3-47.25%
S&P500 52-Week Change 36.00%
52 Week High 394.39
52 Week Low 341.63
50-Day Moving Average 348.21
200-Day Moving Average 354.91

Share Statistics

Avg Vol (3 month) 3579.65k
Avg Vol (10 day) 3560.79k
Shares Outstanding 5N/A
Float 51.39M
% Held by Insiders 112.93%
% Held by Institutions 1102.15%
Shares Short (Jun 28, 2019) 49.08M
Short Ratio (Jun 28, 2019) 417
Short % of Float (Jun 28, 2019) 435.67%
Short % of Shares Outstanding (Jun 28, 2019) 415.47%
Shares Short (prior month May 31, 2019) 48.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-315.88%

Management Effectiveness

Return on Assets (ttm)-24.56%
Return on Equity (ttm)-46.88%

Income Statement

Revenue (ttm)115.85M
Revenue Per Share (ttm)1.99
Quarterly Revenue Growth (yoy)245.00%
Gross Profit (ttm)-248.33M
EBITDA -358.5M
Net Income Avi to Common (ttm)-348.28M
Diluted EPS (ttm)-5.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)524.56M
Total Cash Per Share (mrq)8.94
Total Debt (mrq)75.13M
Total Debt/Equity (mrq)12.11
Current Ratio (mrq)6.89
Book Value Per Share (mrq)10.57

Cash Flow Statement

Operating Cash Flow (ttm)-308.69M
Levered Free Cash Flow (ttm)-166.83M